Estrogen Receptor Negative Neoplasm
2 clinical trials · Condition
◉ Watch Estrogen Receptor Negative Neoplasm
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer (NCT02598310) | Osaka Medical College | 2015-11-01 |
| A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) (NCT02000375) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2013-03-01 |
Track Estrogen Receptor Negative Neoplasm automatically
Every clearance here is in the API, with alerts when new ones post.